Advanced NanoTherapies, Inc
United States
- Los Gatos, California
- 23/08/2023
- Unknown
- $4,000,000
AdvNanoT is based on biodegradable nanoparticles (NP) specifically designed to have higher vascular uptake and cellular retention.
We are developing novel Sirolimus-based medical devices to treat atherosclerosis and blockage for Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD).
- Industry Medical Equipment Manufacturing
- Website http://www.advnanot.com/
- LinkedIn https://www.linkedin.com/company/advanced-nanotherapies/about/
Related People
Marwan Berrada-SounniCo Founder
United States -
Los Gatos, California
With over 20 years of experience in medical device product development, commercialization, and entrepreneurship, I am the CEO and co-founder of Advanced NanoTherapies Inc. This company is revolutionizing the treatment of peripheral arterial disease with biodegradable nanoparticle technology. Our innovative Dual-API-based Drug Coated Balloons (DCB) deliver higher cellular uptake and retention, improving patient outcomes and reducing complications.
As a biomedical engineer and a business development professional, I have a proven track record of launching and leading successful medical device ventures, from seed funding to first-in-man and early sales. I have extensive clinical and device expertise in percutaneous therapies such as electrophysiology, structural heart, cardiovascular, and endovascular devices. I have also obtained patents, FDA approvals, and 510(k) clearances for novel devices and technologies. I am passionate about creating value for patients, physicians, and investors by developing and delivering cutting-edge solutions for unmet medical needs.
Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)